Pigmented Lesion Treatment Market to Reach USD 7,614.7 Million by 2033 at a 7.8% of CAGR, Driven by Advances in Diagnosis and Aesthetic Demand

Pigmented Lesion Treatment Market

The pigmented lesion treatment market is set to expand from USD 3,591.3 million in 2023 to USD 7,614.7 million by 2033, growing at a CAGR of 7.8% over the forecast period. Increasing awareness about skin cancer risks, early diagnosis, and advancements in treatment technologies are key drivers of market growth.

Historically, the market grew at a CAGR of 6.4% (2018–2022), but heightened awareness and technological advancements in imaging tools have pushed the projected growth rate to 7.8% through 2033. Innovations like AI-assisted imaging and dermoscopy are improving early detection and accuracy, increasing the demand for timely interventions.

In addition to medical needs, cosmetic and aesthetic procedures are driving further adoption of pigmented lesion treatments. More individuals are seeking laser therapy, intense pulsed light (IPL), and topical treatments for sunspots, freckles, and other pigmentation concerns, boosting market expansion.

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐚 𝐒𝐚𝐦𝐩𝐥𝐞 𝐨𝐟 𝐭𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 𝐍𝐨𝐰:  https://www.futuremarketinsights.com/report-sample#5245502d47422d35333232

Key Takeaways:

• The pigmented lesion treatment market is projected to grow from USD 3,591.3 million in 2023 to USD 7,614.7 million by 2033, at a CAGR of 7.8%.
• Increased awareness of skin cancer risks and early detection efforts are driving market growth.
• AI-assisted imaging and dermoscopy advancements are improving diagnostic accuracy and treatment efficiency.
• Rising demand for aesthetic treatments is fueling adoption of laser and IPL procedures.
• Public health campaigns and technological innovations are expected to sustain long-term growth.

𝐆𝐞𝐭 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐅𝐮𝐥𝐥 𝐑𝐞𝐩𝐨𝐫𝐭 – https://www.futuremarketinsights.com/reports/pigmented-lesion-treatment-market

𝐊𝐞𝐲 𝐟𝐚𝐜𝐭𝐨𝐫𝐬 𝐢𝐧𝐟𝐥𝐮𝐞𝐧𝐜𝐢𝐧𝐠 𝐦𝐚𝐫𝐤𝐞𝐭 𝐠𝐫𝐨𝐰𝐭𝐡:

• Increased Awareness: Heightened awareness of skin cancer, especially melanoma, has prompted more individuals to pursue early detection and treatment options. Educational campaigns, public health initiatives, and healthcare organizations have all contributed to recognizing the importance of early detection.
• Technological Advancements: Innovations in diagnostic tools like dermoscopy and AI-assisted imaging have improved the accuracy and early detection of potentially malignant lesions. These technologies enhance treatment outcomes and attract patients seeking medical and aesthetic treatments.
• Demand for Cosmetic Enhancements: The market is likely to grow as more people undergo treatment for cosmetic enhancements and aesthetic purposes.

Recent Developments:

• DALEM Project: GMV and the Biomedical Research Foundation of Madrid’s Hospital Universitario La Paz (FIBHULP) initiated the DALEM project, which leverages space technology to monitor pigmented skin lesions.
• Product Innovation: Rohrer Aesthetics unveiled ‘Symmetry’ in October 2023, a laser treatment cleared by the FDA for hand rejuvenation, featuring SwiftScan Intelligent Technology for precise energy delivery.

𝐖𝐡𝐚𝐭 𝐚𝐫𝐞 𝐭𝐡𝐞 𝐥𝐚𝐭𝐞𝐬𝐭 𝐚𝐝𝐯𝐚𝐧𝐜𝐞𝐦𝐞𝐧𝐭𝐬 𝐢𝐧 𝐝𝐢𝐚𝐠𝐧𝐨𝐬𝐭𝐢𝐜 𝐭𝐨𝐨𝐥𝐬 𝐟𝐨𝐫 𝐩𝐢𝐠𝐦𝐞𝐧𝐭𝐞𝐝 𝐥𝐞𝐬𝐢𝐨𝐧𝐬?

Recent advancements in diagnostic tools for pigmented lesions include improvements in both non-invasive imaging techniques and computer-assisted diagnostic methods. These advancements aim to improve the early detection of melanoma and other skin cancers.

Non-Invasive Imaging Techniques:

• Dermoscopy: Dermatoscopy is a non-invasive, state-of-the-art diagnostic method that uses a skin surface microscope to examine pigmented and non-pigmented skin lesions. It improves the early detection of melanoma compared to visual inspection with the naked eye. Dermatoscopy increases the diagnostic sensitivity for melanoma by up to 25%, depending on the physician’s experience.
  • Dermoscopic Algorithms: Various dermoscopic algorithms, such as the ABCD system (asymmetry, border irregularity, color, diameter), 7-point score, 3-point score, Menzies method, and CASH system (color, architecture, symmetry, and homogeneity), aid in the diagnosis of melanoma. The International Dermoscopy Society has initiated a study to create a unified dermoscopy algorithm (UDA) to simplify dermoscopic diagnosis.
• Total Body Photography: Total body photography is a diagnostic aid that improves a clinician’s ability to diagnose melanoma beyond unaided visual inspection and is now considered a mainstream method for early detection.
• In Vivo Reflectance Confocal Microscopy (RCM): RCM is being investigated for its utility in the noninvasive diagnosis of melanoma. Although it has a better resolution than dermatoscopy, dermatoscopy is still the standard method because it is accurate, fast, easy to use, and widely available.
• Multispectral Imaging: This technique uses different wavelengths of light to penetrate the skin at variable depths, providing information on the distribution of collagen, melanin content, and blood vessel distribution within skin lesions. A fully automated system using 15 spectral bands has been reported to achieve a 97% contour accuracy in a sample of 1856 pigmented lesions.
• Optical Coherence Tomography (OCT): OCT is another non-invasive diagnostic and imaging technique.

Computer-Assisted Diagnosis:

• Machine Learning and Automated Diagnosis: One of the most exciting areas of research is using dermatoscopic images for machine learning and automated diagnosis. Convolutional neural networks trained with dermatoscopic images can diagnose pigmented lesions with the same accuracy as human experts.
• AI-Assisted Imaging: AI-assisted imaging is improving the accuracy of early pigmented lesion diagnosis. A 7-class diagnosis AI algorithm has been developed that can diagnose pigmented lesions with equivalent accuracy to specialists.
• Automated Systems: Digitized pigmented lesion images can be analyzed for features such as color, hue, texture, asymmetry, border irregularity, and dimensions. Some systems quantify these features for physician assessment, while others provide a provisional diagnosis, with some achieving a degree of sensitivity and specificity approaching expert dermoscopists.

These advancements, particularly the integration of AI and machine learning, hold promise for improving the accuracy and efficiency of pigmented lesion diagnosis.

Key Players in the Pigmented Lesion Treatment Market

• Lumenis Ltd.
• Alma Laser Inc.
• Zeltic, El.En.
• Cutera
• Sisram
• Allergan Plc
• Cynosure
• Johnson & Johnson
• Bausch Health Group of Companies
• STRATA Skin Sciences
• Solta Medical Inc.
• Lynton’s Laser Ltd.
• Lutronic Corporation
• Fotona d.d.
• Sciton, Inc.

Market Segmentation

By Product:

• Lasers and Energy-based Devices
• Radiofrequency (RF) Devices
• Micro-focused Ultrasound
• Intense Pulsed Light Devices

By Lesion Type:

• Freckles
• Lentigines
• Melisma
• Others

By End-use Sector:

• Dermatology Clinics
• Beauty Clinics

By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube